|
PTPDC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.990240E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.850000E-02 |
| Normal-vs-Stage2 |
2.625600E-01 |
| Normal-vs-Stage3 |
1.956560E-01 |
| Normal-vs-Stage4 |
4.238600E-01 |
| Stage1-vs-Stage2 |
1.466080E-02 |
| Stage1-vs-Stage3 |
8.825600E-01 |
| Stage1-vs-Stage4 |
2.370400E-02 |
| Stage2-vs-Stage3 |
6.322400E-02 |
| Stage2-vs-Stage4 |
7.277000E-01 |
| Stage3-vs-Stage4 |
7.109700E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.346300E-02 |
| Normal-vs-AfricanAmerican |
4.455600E-01 |
| Normal-vs-Asian |
3.648000E-01 |
| Caucasian-vs-AfricanAmerican |
6.562200E-01 |
| Caucasian-vs-Asian |
4.658800E-01 |
| AfricanAmerican-vs-Asian |
9.295000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.357800E-01 |
| Normal-vs-Female |
1.925790E-01 |
| Male-vs-Female |
7.889600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.854400E-02 |
| Normal-vs-Age(41-60Yrs) |
3.548600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.596600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.965000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.220800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.900390E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.211000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.264300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.276800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.124400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.309900E-02 |
| Classical-VS-Follicular |
1.40909994783556E-09 |
| Classical-VS-Other |
8.734000E-01 |
| Classical-VS-Normal |
8.059300E-03 |
| Tall-VS-Follicular |
1.757820E-02 |
| Tall-VS-Other |
5.897000E-01 |
| Tall-VS-Normal |
9.180800E-01 |
| Follicular-VS-Other |
2.965800E-01 |
| Follicular-VS-Normal |
5.635900E-03 |
| Other-VS-Normal |
5.716000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.174000E-01 |
| Normal-vs-N1 |
5.182300E-02 |
| N0-vs-N1 |
4.526400E-02 |
|
|
